The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase (Ph) 1/2 trial of rituximab (RX), imprime PGG (IP), and alemtuzumab (AL) in the early treatment of patients (Pts) with high risk chronic lymphocytic leukemia (CLL).
 
Nandita Bose
Employment - Biothera
Stock and Other Ownership Interests - Biothera
 
Clive Zent
Research Funding - Biothera (Inst); GlaxoSmithKline (Inst); Novartis (Inst)
 
George J. Weiner
No Relationships to Disclose
 
Betsy LaPlant
No Relationships to Disclose
 
Nadine Ottoson
Employment - Biothera
Stock and Other Ownership Interests - Biothera
 
Steven Leonardo
Employment - Biothera
 
Adria Jonas
Employment - Biothera
Stock and Other Ownership Interests - Biothera
 
Richard Dale Huhn
Employment - Biothera
Stock and Other Ownership Interests - Biothera
 
Ada H. Braun
Employment - Biothera
Stock and Other Ownership Interests - Biothera
 
Stephen Maxted Ansell
Honoraria - Research to Practice; WebMD
Research Funding - Bristol-Myers Squibb (Inst); Celldex (Inst); Seagen (Inst)